Goldiam International Earnings Call Transcripts
Fiscal Year 2027
-
Q2 and H1 revenue, EBITDA and PAT grew strongly as existing retailer wallet share expanded and new international accounts contributed. Management expects sustained margins and growth, while scaling ORIGEM through improving store productivity and selective expansion.
-
Q1 FY 2027 delivered strong revenue, EBITDA and PAT growth, with a 24% steady-state EBITDA margin. Management expects robust Q2–Q3 trading and sees further B2B expansion, while scaling ORIGEM stores and sales per store.
Fiscal Year 2026
-
FY 2026 set records, with Q4 revenue up 21% and PAT up 61%. Management expects FY 2027 double-digit growth and stronger margins, while scaling ORIGEM toward 45–50 stores.
-
Q3 revenue grew 18% and 9M revenue 30%, with PAT growth of 37% and 42%. Management cited strong orders, continued export expansion and an aggressive ORIGEM rollout, while targeting a record FY26.
-
Q2 and H1 revenue and profits rose more than 40% YoY despite U.S. tariff disruption, with U.S. casting mitigating exposure. ORIGEM expansion is funded by a INR 202 crore QIP, while margin guidance remains 18%–22%.
Fiscal Year 2025
-
FY2025 revenue rose 30% and PAT 29%, with a 22.4% EBITDA margin. Tariffs may soften early FY2026 margins, while B2B growth and ORIGEM expansion underpin the outlook.
-
H1 revenue rose 19% and EBITDA 21%, while Q2 shipments shifted into October. Management expects a strong next quarter, targets 18%–22% EBITDA margins and is launching an India retail expansion.
-
Q1 FY25 total income rose 40% YoY, with 20.1% EBITDA margin and lab-grown diamonds at 68% of revenue. FY25 growth guidance is 15%–20% or more, alongside ORIGEM’s planned India retail launch.
Fiscal Year 2024
-
Q4 revenue rose 12% YoY and EBITDA rose 21%, while LGD reached 49% of FY revenue. Erah retail launches are planned from Q3 FY25, supported by B2B cash flows and phased store investment.
-
Revenue grew against a contracting industry as lab-grown jewelry mix rose to 34%-35%. Margins were affected by INR 10 crore-INR 12 crore of H1 inventory realignment, while management cited a 20%-25% EBITDA margin range and continued geographic expansion.